Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...
Saved in:
Main Authors: | Xiang Tong (Author), Shijie Zhang (Author), Dongguang Wang (Author), Li Zhang (Author), Jizheng Huang (Author), Tianli Zhang (Author), Hong Fan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
by: Jizhen Huang, et al.
Published: (2020) -
Fisetin Alleviated Bleomycin-Induced Pulmonary Fibrosis Partly by Rescuing Alveolar Epithelial Cells From Senescence
by: Li Zhang, et al.
Published: (2020) -
Human Endometrial Regenerative Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Yiming Zhao, et al.
Published: (2018) -
Clinical Characteristics and Prognostic Analysis of Patients With Pulmonary Tuberculosis and Type 2 Diabetes Comorbidity in China: A Retrospective Analysis
by: Shijie Zhang, et al.
Published: (2021) -
Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Aastha Arora, et al.
Published: (2018)